HappeningToo topic
Metoroprolol Tartrate reports
Browse community reports connected to Metoroprolol Tartrate. These reports can show that other people are describing similar experiences, but they do not prove that Metoroprolol Tartrate caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
44 problems
Abdominal Discomfort while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and abdominal discomfort appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and abdominal pain upper appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and abdominal pain appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and acid reflux appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and alopecia appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and anxiety appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and back pain appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chest Discomfort while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and chest discomfort appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and constipation appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and cough appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and decreased appetite appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and dehydration appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and diarrhea appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and dizziness appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and dyspepsia appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and excessive sweating appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and fatigue appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and feeling abnormal appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and flushing appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and headache appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Heart Rate Increased while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and heart rate increased appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hot Flush while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and hot flush appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and hypotension appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and insomnia appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and itching appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and malaise appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and muscle spasms appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and muscular weakness appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and myalgia appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and nausea appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and pain appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and palpitations appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and peripheral swelling appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and rash appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and shortness of breath appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and skin redness appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and sleepiness appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and tingling or pins and needles appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and tremor appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and vision blurred appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and vomiting appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and weakness appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and weight decreased appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Metoroprolol Tartrate
FDA FAERS contains adverse-event reports in which Metoroprolol Tartrate and weight increased appear together. This does not establish that Metoroprolol Tartrate caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →